Triller Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Triller Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.62M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $27.48M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $54.19M | Jan 26, 2026 |
| FY2022 | Dec 31, 2022 | $31.08M | Apr 3, 2023 |
| FY2022 | Dec 31, 2021 | $11.47M | Apr 3, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($174.54M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($1.14B) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($49.21M) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | ($44.52M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $96.46M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($37.4K) | Mar 14, 2022 |
| FY2019 | Dec 31, 2019 | ($15.4K) | Mar 31, 2020 |
| FY2019 | Dec 31, 2018 | ($2.5K) | Mar 31, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($138.41M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($113.18M) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($43.06M) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | ($28.35M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($8.45M) | Apr 3, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.13M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $3.18M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $4.56M | Jan 26, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($25.94M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($29.04M) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($42.28M) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | ($19.30M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($2.15M) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($503.9K) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($355.1K) | Dec 13, 2021 |
| FY2019 | Dec 31, 2018 | ($2.5K) | Mar 31, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $105.0K | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | $968.4K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.6K | Apr 3, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.51M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $50.58M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $66.59M | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | $101.22M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $122.51M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $48.95M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $47.56M | Dec 13, 2021 |
| FY2019 | Dec 31, 2018 | $72.5K | Mar 31, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $363.62M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $296.55M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $58.49M | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | $74.07M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $61.36M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $4.44M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.91M | Dec 13, 2021 |
| FY2019 | Dec 31, 2018 | $75.0K | Mar 31, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($328.12M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($245.97M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2023 | $8.10M | Apr 14, 2026 |
| FY2024 | Dec 31, 2022 | $27.15M | Jan 26, 2026 |
| FY2023 | Dec 31, 2021 | $61.15M | Mar 28, 2024 |
| FY2021 | Dec 31, 2020 | ($1.48M) | Mar 14, 2022 |
| FY2021 | Dec 31, 2019 | ($1.36M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | ($2.5K) | Dec 13, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.01B | Jan 26, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.38B) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($1.20B) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($65.60M) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | ($16.40M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $52.13M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($1.49M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($1.46M) | Dec 13, 2021 |
| FY2019 | Dec 31, 2018 | ($2.5K) | Mar 31, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.29M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $3.07M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $1.86M | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | $6.45M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $38.60M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $672.4K | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $929.3K | Dec 13, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | (18) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Apr 3, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | (18) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Apr 3, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 175.29M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 138.14M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | 33.24M | Jan 26, 2026 |
| FY2023 | Dec 31, 2022 | 58.38M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 53.84M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | 1.38M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 1.38M | Dec 13, 2021 |
| FY2019 | Dec 31, 2018 | 1,000 | Mar 31, 2020 |